Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AML
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pilot Imaging Study of Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE1
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Guadecitabine Extension Study
- Status
- TERMINATED
- Phase
- PHASE2
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients
- Status
- COMPLETED
- Phase
- PHASE3
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
NGS in AML Relapse
- Status
- UNKNOWN
- Phase
- N/A
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1